Delivery Order SPE2DB20D3101-SPE2DB24FQTQ4
Award Date 10/26/23
Potential Completion Date 10/27/23
Potential Value $1.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with ID SPE2DX15D3012|SPE2DX24F8DG3, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,627,934 units of the pharmaceutical product Atomoxetine HCL 100 mg capsules, with an ultimate completion date of October 30, 2023 and a ceiling value of $1,326.76. The contract is a delivery order under a larger Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Atomoxetine HCL 60 mg capsules. The contract has a ceiling value of $1,069.76 and a performance period ending on December 12, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,342.24 delivery order is for the supply of 4,563,501,236 units of Atomoxetine HCL 25 mg capsules. The order is placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical...
- This federal contract award, valued at $1,699.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor, for the delivery of Atomoxetine HCL 40 mg capsules. The contract has a completion date of February 13, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,244.48 firm fixed-price delivery order is for the supply of Atomoxetine HCL 25 mg capsules. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Atomoxetine HCL 18 mg capsules. The award, with a ceiling value of $1,265.40, is structured as a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a maximum value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical...
- This federal contract award, valued at $1,090.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4564513416 - Atomoxetine HCL 40 mg Capsule 30s, a pharmaceutical product. The contract has a Firm Fixed Price and Delivery Order type, with a completion date of May 7, 2024. The contract was awarded without any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp and its...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,561.84 fixed-price delivery order is for the supply of Atomoxetine HCL 25 mg capsules. The award is a child order under a larger Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Cencora, Inc. to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Atomoxetine HCL 18 mg capsules, with a ceiling value of $2,205.42 and a performance period extending to May 27, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,422.91 to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Atomoxetine HCL 25 mg capsules (30-count units). The contract, which is not set-aside and was competitively awarded, carries a firm fixed-price structure with an ultimate completion date of January 16, 2026. Performance will be executed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a...